Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.19.2
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Current Assets:    
Cash and cash equivalents $ 10,455 $ 2,671
Short-term investments 5,000  
Deferred financing costs 61 1,702
Prepaid expenses and other current assets 161 152
Total Assets 15,677 4,525
Current Liabilities:    
Accounts payable and accrued expenses 1,728 4,669
Accounts payable and accrued expenses - related party 45 487
Total current liabilities 1,773 5,156
Total Liabilities 1,773 5,156
Commitments and Contingencies
Stockholders' Equity (Deficit)    
Common Stock ($0.0001 par value), 50,000,000 shares authorized Common shares; 16,559,747 and 10,667,714 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively 2 1
Additional paid-in capital 74,362 41,577
Accumulated deficit (60,460) (42,209)
Total Stockholders' Equity (Deficit) 13,904 (631)
Total Liabilities and Stockholders' Equity (Deficit) 15,677 4,525
Series A Preferred Stock [Member]    
Stockholders' Equity (Deficit)    
Preferred Stock ($0.0001 par value), 2,000,000 shares authorized Class A Preferred Stock, 250,000 shares issued and outstanding as of June 30, 2019 and December 31, 2018 $ 0 $ 0